Adjuvant Trastuzumab Passes the Test of Time
Journal of Clinical Oncology (JCO) Podcast · Journals Online Team
November 25, 20147m 3s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Long-term follow up from the landmark, NCI-sponsored adjuvant trastuzumab trials confirms the clinical benefits and clinical safety of this important therapy.